|
|
Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin ... - PR Newswire (press release) |
|
PR Newswire (press release)Notably, in these trials in type 2 diabetes patients with mild and moderate renal impairment, linagliptin blood plasma levels were comparable to those seen ...Boehringer's First Diabetes Pill Lowered Blood Sugar in Study BusinessWeekBoehringer Ingelheim Announces Results of Phase III Data Showing That ... |
|
|
Dialysis a long way from home - Sydney Morning Herald |
|
Sydney Morning HeraldHEALTH experts are calling for a co-ordinated national approach to kidney dialysis after some patients travelling long distances for treatment - because of ... |
|
Excessive calcium could be harmful - Times of India |
|
Times of IndiaPostmenopausal and pregnant women, transplant recipients, patients with bulimia (an eating disorder) and individuals on dialysis face the highest risk of ... |
|
ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy ... - MarketWatch (press release) |
|
MarketWatch (press release)Patients with Renal Impairment: The dose of ONGLYZA is 2.5 mg once daily for patients with moderate or severe renal impairment, or with end-stage renal ...52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non ... Trading Markets (press release)Bristol-Myers Squibb, AstraZeneca Announce Results Up To 76-weeks From Phase 3 ... |
|
Original Kinks' bassist Pete Quaife dies at 66 - Belleville Intelligencer |
|
Belleville IntelligencerThe exact cause of death is unknown, but suffered renal failure more than 12 years ago and had been taking kidney dialysis for more than 12 years. ... |
|
|
|
|
<< Start < Prev 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 Next > End >>
|
|
Page 1489 of 2630 |